Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) Target Price at $122.70
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating […]
More Stories
Elevation Oncology’s (ELEV) “Market Perform” Rating Reaffirmed at William Blair
Elevation Oncology (NASDAQ:ELEV – Get Free Report)‘s stock had its “market perform” rating reaffirmed by research analysts at William Blair...
Broadcom (NASDAQ:AVGO) Price Target Raised to $265.00 at Barclays
Broadcom (NASDAQ:AVGO – Get Free Report) had its price target increased by equities researchers at Barclays from $215.00 to $265.00...
Mizuho Begins Coverage on Etoro Group (NASDAQ:ETOR)
Stock analysts at Mizuho started coverage on shares of Etoro Group (NASDAQ:ETOR – Get Free Report) in a research report...
Citizens Jmp Begins Coverage on Etoro Group (NASDAQ:ETOR)
Stock analysts at Citizens Jmp assumed coverage on shares of Etoro Group (NASDAQ:ETOR – Get Free Report) in a research...
Bank of America Lowers ArcBest (NASDAQ:ARCB) Price Target to $63.00
ArcBest (NASDAQ:ARCB – Get Free Report) had its price target lowered by research analysts at Bank of America from $67.00...
Etoro Group (NASDAQ:ETOR) Now Covered by Jefferies Financial Group
Jefferies Financial Group started coverage on shares of Etoro Group (NASDAQ:ETOR – Get Free Report) in a research report issued...